Published
FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD
No abstract availability was recorded for this entry.
No abstract availability was recorded for this entry.
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.